Article History
Accepted: 26 May 2021
First Online: 21 June 2021
Declarations
:
: No funding was received for the preparation of this manuscript.
: Egídio Freitas has no conflicts of interest to declare. Emma Guttman-Yassky declares the following conflicts of interest: AbbVie, Almirall, Amgen, AnaptysBio, Asana Biosciences, Boehringer Ingelheim, Cara Therapeutics, Celgene, Concert, DBV, Dermira, Dermavant, DS Biopharma, Eli Lilly, EMD Serono, Escalier, Galderma, Glenmark, Innovaderm, Janssen Pharmaceuticals, Kiniksa, Kyowa Kirin, LEO Pharma, Mitsubishi Tanabe, Novan, Pfizer, Ralexar, RAPT Therapeutics, Regeneron, Sanofi, Sienna Biopharma, UCB, and Union Therapeutics. Tiago Torres declares the following conflicts of interest: AbbVie, Amgen, Almirall, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Janssen, Biocad, LEO Pharma, Eli Lilly, MSD, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme and Sandoz.
: EF, EG, and TT had the idea for the article, performed the literature search and data analysis, and drafted and critically revised the work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.